Department of Clinical Psychology, University of Kurdistan, Sanandaj, Iran.
Clin Rehabil. 2020 Jul;34(7):938-947. doi: 10.1177/0269215520923135. Epub 2020 May 31.
To evaluate the effectiveness of acceptance and commitment therapy (ACT) on depressive symptoms in physically disabled persons.
Randomized controlled trial.
State welfare organization in Kamyaran, Kurdistan, Iran.
Fifty-two physically disabled participants with a primary diagnosis of depression were randomly assigned to either ACT or control groups.
Participants in the ACT group ( = 23) received eight weekly 90-minute group sessions based on standard ACT protocol for depression. Participants in the control group ( = 29) received psychoeducation regarding depression.
Measures were recorded at baseline, eight weeks (end of treatment), and 16 weeks (follow-up). The outcomes were the change in the depressive symptoms, measured by Beck Depression Inventory-II (BDI-II), psychological flexibility, emotion regulation, and psychological well-being measured by Acceptance and Action Questionnaire-II (AAQ-II), Emotion Regulation Questionnaire (ERQ), and Scales of Psychological Well-Being (SPWB), respectively.
After eight weeks, significant changes in depressive symptoms was observed in the experimental group (ACT -10.39 ± 0.79 vs control 0.66 ± 0.68, < 0.001). Compared to the control group, the experimental group also showed significant improvement in psychological flexibility (ACT 8.13 ± 0.52 vs control -0.03 ± 0.51, < 0.001), adaptive emotion regulation strategies (ACT 10.74 ± 0.62 vs control 0.03 ± 1.03, < 0.001), and psychological well-being (ACT 66.95 ± 4.01 vs control -1.90 ± 1.04, < 0.001).
Compared with control group, ACT significantly reduced the participants' depression, and changed psychological flexibility, emotion regulation, and psychological well-being in persons with physical disability.
评估接纳与承诺疗法(ACT)对肢体残疾者抑郁症状的疗效。
随机对照试验。
伊朗库尔德斯坦卡米亚兰的一家州立福利机构。
52 名肢体残疾者,主要诊断为抑郁症,随机分为 ACT 组或对照组。
ACT 组(n=23)接受了 8 周每周 90 分钟的团体治疗,基于标准的 ACT 抑郁治疗方案。对照组(n=29)接受了关于抑郁的心理教育。
在基线、8 周(治疗结束时)和 16 周(随访时)记录结果。结果是通过贝克抑郁量表第二版(BDI-II)评估的抑郁症状变化、接纳与行动问卷第二版(AAQ-II)评估的心理灵活性、情绪调节,以及心理幸福感量表(SPWB)评估的情绪调节问卷(ERQ)和心理幸福感量表(SPWB)评估的心理幸福感。
8 周后,实验组(ACT-10.39±0.79 vs 对照组 0.66±0.68, < 0.001)的抑郁症状有显著变化。与对照组相比,实验组在心理灵活性(ACT 8.13±0.52 vs 对照组-0.03±0.51, < 0.001)、适应性情绪调节策略(ACT 10.74±0.62 vs 对照组 0.03±1.03, < 0.001)和心理幸福感(ACT 66.95±4.01 vs 对照组-1.90±1.04, < 0.001)方面也有显著改善。
与对照组相比,ACT 显著降低了参与者的抑郁程度,并改变了肢体残疾者的心理灵活性、情绪调节和心理幸福感。